Deakin University / All Locations

Nearby Subjects are:

Result Page Prev Next

Add Marked to Bag Add All On Page Add Marked to My Lists
Mark		Year	Entries
	Simian virus 40 -- drug effects : The SV40 replicon model for analysis of anticancer drugs / Robert M. Snapka	1996	1
	Skin -- drug effects		13
	Skin Absorption -- drug effects		4
	Skin Aging -- drug effects : Botulinum toxin in facial rejuvenation / Kate Coleman	2020	1
	Sleep -- drug effects		2
	Solubility -- drug effects		3
	Staphylococcus aureus -- drug effects : MRSA / edited by John A. Weigelt	2007	1
	Stem Cells -- drug effects : Human stem cell toxicology / [editors] James L. Sherley, Diana Anderson	2016	1
	Sympathetic Nervous System -- drug effects : Neural control of renal function / Ulla C. Koop	2011	1
	Synaptic Transmission -- drug effects.		3
	Thirst -- drug effects : Neurobiology of body fluid homeostasis : transduction and integration / edited by Laurival Antonio De Luca Jr., José Vanderlei Menani, Alan Kim Johnson	2014	1
	Tissues -- drug effects : Tissue analysis for drug development / editor, Stacy Ho	2013	1
	Variation (Genetics) -- drug effects : Pharmacogenetics / edited by Ian P. Hall, Munir Pirmohamed	2006	1
	Vestibular Nerve -- drug effects : Ototoxicity / [edited by] Peter S. Roland, John A. Rutka	2004	1
	Viruses -- drug effects		3
	Vitreous Body -- drug effects : Pharmacology and vitreoretinal surgery / volume editor, Arnd Gandorfer	2009	1
	Wakefulness -- drug effects : Caffeine for the sustainment of mental task performance : formulations for military operations / Committee on Military Nutrition Research, Food and Nutrition Board	2001	1
	Weight Loss -- drug effects : Obesity : epidemiology, pathophysiology, and prevention / edited by Debasis Bagchi, Harry G. Preuss	2007	1
	Yeasts -- drug effects : Interactions of yeasts, moulds, and antifungal agents : how to detect resistance / Gerri S. Hall, editor	2012	1
	Drug efficacy -- See Drugs Effectiveness --subdivision Effectiveness under individual drugs and groups of drugs and subdivision Therapeutic use--Effectiveness under individual chemicals and groups of chemicals, e.g. Insulin--Therapeutic use--Effectiveness; Analgesics--Effectiveness		1
	Drug-Eluting Stent -- See Drug-Eluting Stents Stents that are covered with materials that are embedded with chemicals that are gradually released into the surrounding milieu		1
	Drug emulsifying agents -- See Excipients		1
	Drug enforcement -- See Drug control Here are entered general and non-legal works on the control of drugs. Works on the legal aspects of drug control are entered under Drugs--Law and legislation		1
	Drug enforcement agents.		12
	Drug enforcement agents -- Australia -- Biography : Operation Jungle / John Shobbrook	2021	1
	Drug enforcement agents -- California -- Los Angeles -- Case studies : Operation Fly Trap : L.A. gangs, drugs, and the law / Susan A. Phillips	2012	1
	Drug enforcement agents -- California -- Los Angeles -- Drama : Training day	2014	1
	Drug enforcement agents -- Fiction. : Immunity / Lori Andrews	2008	1
	Drug enforcement agents -- Great Britain : Taking care of business : police detectives, drug law enforcement and proactive investigation / Matthew Bacon	2016	1
	Drug enforcement agents -- United States		2
	Drug Error, High-Alert -- See Medication Errors Errors in prescribing, dispensing, or administering medication with the result that the patient fails to receive the correct drug or the indicated proper drug dosage		1
	Drug errors -- See Medication errors		1
	Drug Eruption -- See Drug Eruptions Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions		1
	Drug Eruption, Maculopapular -- See Drug Eruptions Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions		1
	Drug-eruptions -- See Drug-exanthems		1
	Drug Eruptions		9
	Drug Eruptions -- etiology : Drug eruptions Haur Yueh Lee, Daniel Creamer, editors	2022	1
	Drug Eruptions, Maculopapular -- See Drug Eruptions Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions		1
	Drug Evaluation -- See Also Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.		1
	Drug Evaluation		69
	Drug Evaluation -- ethics		3
	Drug Evaluation, FDA Phase 1 -- See Clinical Trials, Phase I as Topic Works about studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the U.S. and in other countries		1
	Drug Evaluation, FDA Phase 2 as Topic -- See Clinical Trials, Phase II as Topic Works about studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries		1
	Drug Evaluation, FDA Phase 3 as Topic -- See Clinical Trials, Phase III as Topic Works about comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries		1
	Drug Evaluation, FDA Phase 4 as Topic -- See Clinical Trials, Phase IV as Topic Planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the U.S. and in other countries		1
	Drug Evaluation, FDA Phase I -- See Clinical Trials, Phase I as Topic Works about studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the U.S. and in other countries		1
	Drug Evaluation, FDA Phase I as Topic -- See Clinical Trials, Phase I as Topic Works about studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the U.S. and in other countries		1
	Drug Evaluation, FDA Phase II as Topic -- See Clinical Trials, Phase II as Topic Works about studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries		1
	Drug Evaluation, FDA Phase III as Topic -- See Clinical Trials, Phase III as Topic Works about comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries		1
	Drug Evaluation, FDA Phase IV as Topic -- See Clinical Trials, Phase IV as Topic Planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the U.S. and in other countries		1
Add Marked to Bag Add All On Page Add Marked to My Lists

Result Page Prev Next

Limit/Sort Search Search as Words

Drug efficacy -- See Drugs Effectiveness

Drug-Eluting Stent -- See Drug-Eluting Stents

Drug emulsifying agents -- See Excipients

Drug enforcement -- See Drug control

Drug Error, High-Alert -- See Medication Errors

Drug errors -- See Medication errors

Drug Eruption -- See Drug Eruptions

Drug Eruption, Maculopapular -- See Drug Eruptions

Drug-eruptions -- See Drug-exanthems

Drug Eruptions, Maculopapular -- See Drug Eruptions

Drug Evaluation -- See Also Clinical Trials as Topic

Drug Evaluation, FDA Phase 1 -- See Clinical Trials, Phase I as Topic

Drug Evaluation, FDA Phase 2 as Topic -- See Clinical Trials, Phase II as Topic

Drug Evaluation, FDA Phase 3 as Topic -- See Clinical Trials, Phase III as Topic

Drug Evaluation, FDA Phase 4 as Topic -- See Clinical Trials, Phase IV as Topic

Drug Evaluation, FDA Phase I -- See Clinical Trials, Phase I as Topic

Drug Evaluation, FDA Phase I as Topic -- See Clinical Trials, Phase I as Topic

Drug Evaluation, FDA Phase II as Topic -- See Clinical Trials, Phase II as Topic

Drug Evaluation, FDA Phase III as Topic -- See Clinical Trials, Phase III as Topic

Drug Evaluation, FDA Phase IV as Topic -- See Clinical Trials, Phase IV as Topic